![Anthony DiGiandomenico](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony DiGiandomenico
Fondatore presso
MDB CAPITAL HOLDINGS, LLC
Patrimonio netto: 5 M $ in data 31/05/2026
Profilo
Anthony DiGiandomenico is the founder of Public Ventures LLC, founded in 1997, and MDB Capital Holdings LLC, founded in 1997, where the title held is Director & Chief Transactions.
Current jobs include Independent Director at ClearSign Technologies Corp.
starting in 2025; Director at Pier Acquisition I, Inc.; Director at Pier Acquisition II, Inc.; Independent Director at ENDRA Life Sciences, Inc. since 2013; Managing Director at National Association of Securities Dealers, Inc. since 1997; Independent Director at Illumination Acquisition Corp.
I starting in 2026; and Director at eXoZymes, Inc. since 2019.
Former jobs include President & Chief Executive Officer at Digian Co.; Director at Orion Acquisition Corp.
II; Director at Charlie's Holdings, Inc. from 2004 to 2012; Director at Cue Biopharma, Inc. from 2016 to 2019; and Independent Director at Provention Bio, Inc. from 2017 to 2020.
Education includes undergraduate studies at The University of Colorado and an MBA from Haas School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/09/2025 | 1.245.000 ( 24,9% ) | 4 M $ | 31/05/2026 | |
| 25/06/2026 | 76.267 ( 6% ) | 419 469 $ | 31/05/2026 | |
| 30/09/2025 | 80.693 ( 1,48% ) | 282 426 $ | 31/05/2026 | |
| 30/06/2026 | 54.447 ( 1,01% ) | 252 090 $ | 31/05/2026 | |
EXOZYMES INC. -.--% | 09/06/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Anthony DiGiandomenico
| Società | Posizione | Inizio |
|---|---|---|
| ENDRA LIFE SCIENCES INC. | Direttore/Membro del Consiglio | 01/07/2013 |
| MDB CAPITAL HOLDINGS, LLC | Fondatore | 01/01/1997 |
| EXOZYMES, INC. | Direttore/Membro del Consiglio | 01/04/2019 |
| CLEARSIGN TECHNOLOGIES CORPORATION | Direttore/Membro del Consiglio | 22/05/2025 |
Pier Acquisition I, Inc.
 Pier Acquisition I, Inc. Financial ConglomeratesFinance Operates as a blank check company | Direttore/Membro del Consiglio | 16/11/2009 |
Pier Acquisition II, Inc.
 Pier Acquisition II, Inc. Financial ConglomeratesFinance Operates as a blank check company | Direttore/Membro del Consiglio | 16/11/2009 |
National Association of Securities Dealers, Inc.
 National Association of Securities Dealers, Inc. Investment Banks/BrokersFinance Provides financial regulatory services | Corporate Officer/Principal | 25/07/2011 |
Precedenti posizioni note di Anthony DiGiandomenico
| Società | Posizione | Fine |
|---|---|---|
| PROVENTION BIO, INC. | Direttore/Membro del Consiglio | 19/05/2020 |
| CUE BIOPHARMA, INC. | Direttore/Membro del Consiglio | 03/10/2019 |
| ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ | - |
Formazione di Anthony DiGiandomenico
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
47
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Orion Acquisition Corp. II
 Orion Acquisition Corp. II Financial ConglomeratesFinance Development stage company | Finance |
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Charlies Holdings, Inc.
 Charlies Holdings, Inc. Industrial ConglomeratesProducer Manufacturing Manufactures and sells nicotine-based vapor products | Producer Manufacturing |
ClearSign Technologies Corp.
 ClearSign Technologies Corp. Industrial MachineryProducer Manufacturing Operates as a development stage company that designs and develops technologies for combustion systems | Producer Manufacturing |
Pier Acquisition I, Inc.
Pier Acquisition I, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Pier Acquisition II, Inc.
Pier Acquisition II, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ENDRA Life Sciences, Inc.
 ENDRA Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops medical imaging technology solutions | Health Technology |
National Association of Securities Dealers, Inc.
National Association of Securities Dealers, Inc. Investment Banks/BrokersFinance Provides financial regulatory services | Finance |
Digian Co. | |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
MDB Capital Holdings LLC
 MDB Capital Holdings LLC Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Invizyne Technologies, Inc.
 Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Manufactures and sells chemicals for pharmaceuticals, fuels, materials, food additives & novel compounds | Process Industries |
